Cargando…

Dexamethasone/methylprednisolone/tocilizumab: Candidaemia: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602537/ http://dx.doi.org/10.1007/s40278-021-05641-4

Ejemplares similares

Tocilizumab: Candidaemia and Off-label-use: 3 case reports
Publicado: (2020)

Dexamethasone/methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Lack of efficacy: case report
Publicado: (2021)

Dexamethasone/methylprednisolone/prednisolone: Psychosis: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities: case report
Publicado: (2022)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Fungal sepsis and pseudomonal pneumonia: 2 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Disseminated strongyloidiasis and off-label use: case report
Publicado: (2020)

Dexamethasone/methylprednisolone/steroids: Hypertension: 2 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities: 2 case reports
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Gastrointestinal perforation following off label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Lack of efficacy in off-label use: 7 case reports
Publicado: (2021)

Ciclosporin/methylprednisolone/tocilizumab: COVID-19 pneumonia, leukopenia and neutropenia: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022)

Dexamethasone/eltrombopag/methylprednisolone: Lack of efficacy: 2 case reports
Publicado: (2022)

Dexamethasone/methylprednisolone: Mucormycosis and gastrointestinal mucormycosis: 7 case reports
Publicado: (2022)

Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Hepatotoxicity, cytomegalovirus reactivation and off label use: 2 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Antibacterials/dexamethasone/methylprednisolone: Suspected invasive bronchopulmonary aspergillosis: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Off label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/methylprednisolone: Off-label use and cryptococcal meningoencephalitis: case report
Publicado: (2022)

Dexamethasone/prednisone/tocilizumab: Worsening of Strongyloides infection: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Herpes Simplex virus type I reactivation and hyperglycaemia: 2 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Methicillin-sensitive Staphylococcus aureus costochondritis and chest wall abscess: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Various toxicities, off label use and lack of efficacy: 2 case reports
Publicado: (2022)

Dexamethasone/methylprednisolone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Azithromycin/dexamethasone/methylprednisolone: Aspergillosis, mucormycosis and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Prolongation of the coronavirus disease 2019 viral clearance time: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities following off label use: 21 case reports
Publicado: (2022)

Dexamethasone/methylprednisolone: Osteonecrosis of the knee following off-label use: 2 case reports
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h72on36fonh60qaafhaen38dj6